非洛地平联合吲达帕胺治疗高血压疗效观察

Felodipine Indapamide Combined Hypertension Therapy

目的:观察非洛地平与吲达帕胺治疗高血压的疗效。方法:将1级、2级高血压患者60例随机分为两组,非洛地平、吲达帕胺组30例(每日10 mg、2.5 mg,晚餐后口服),卡托普利为对照组30例(75 mg/d,分3次口服),连续治疗8周。结果:两组之间治疗高血压没有显著性差异,但控制24 h血压非洛地平与吲达帕胺更好,同时副作用发生率更低。结论:非洛地平联合吲达帕胺是治疗高血压有效安全的药物。

Objective： To observe the felodipine treatment with indapamide hypertension.Methods： 1,2 hypertensive patients were randomly divided into two groups of 60 cases of felodipine,indapamide group of 30 patients（daily 10mg,2.5mg,a dinner after the oral）,captopril for the control group 30 cases（75mg / d,at 3 times the oral）,continuous treatment for 8 weeks.Results： Treatment of hypertension between the two groups there were no significant differences,but the 24h blood pressure control with felodipine indapamide better,at the same time lower the incidence of side effects.Conclusion： The combined felodipine indapamide is effective and safe treatment of high blood pressure drugs.